137 related articles for article (PubMed ID: 15010888)
41. Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1beta or interleukin 6 in vitro.
Hedger MP; Phillips DJ; de Kretser DM
Cytokine; 2000 Jun; 12(6):595-602. PubMed ID: 10843734
[TBL] [Abstract][Full Text] [Related]
42. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
Ju EM; Choi KC; Hong SH; Lee CH; Kim BC; Kim SJ; Kim IH; Park SH
Biochem Biophys Res Commun; 2005 Mar; 328(4):1170-81. PubMed ID: 15708000
[TBL] [Abstract][Full Text] [Related]
43. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
Karlsson G; Liu Y; Larsson J; Goumans MJ; Lee JS; Thorgeirsson SS; Ringnér M; Karlsson S
Physiol Genomics; 2005 May; 21(3):396-403. PubMed ID: 15769904
[TBL] [Abstract][Full Text] [Related]
44. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
[TBL] [Abstract][Full Text] [Related]
45. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase.
Huang HM; Chang TW; Liu JC
Biochem Biophys Res Commun; 2004 Aug; 320(4):1247-52. PubMed ID: 15249224
[TBL] [Abstract][Full Text] [Related]
46. Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer.
Karlsson S; Holmberg E; Askerlund A; Levan KK
Cancer Genet Cytogenet; 2007 Aug; 177(1):43-50. PubMed ID: 17693190
[TBL] [Abstract][Full Text] [Related]
47. Identification of FOXC1 as a TGF-beta1 responsive gene and its involvement in negative regulation of cell growth.
Zhou Y; Kato H; Asanoma K; Kondo H; Arima T; Kato K; Matsuda T; Wake N
Genomics; 2002 Nov; 80(5):465-72. PubMed ID: 12408963
[TBL] [Abstract][Full Text] [Related]
48. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
49. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
50. Activin and follistatin in rat mammary gland.
Bussmann UA; Lanuza GM; Bussmann LE
Mol Cell Endocrinol; 2004 Jun; 221(1-2):9-19. PubMed ID: 15223128
[TBL] [Abstract][Full Text] [Related]
51. [The expression of activin A and transforming growth factor-beta 1 during rabbit mandibual distraction osteogenesis].
Li X; Qi ZL; Dong JS; Wang W; Lin XX; Dai CC
Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Nov; 19(6):445-9. PubMed ID: 15004902
[TBL] [Abstract][Full Text] [Related]
52. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
[TBL] [Abstract][Full Text] [Related]
53. Identification of tocopherol-associated protein as an activin/TGF-beta-inducible gene in mast cells.
Funaba M; Murakami M; Ikeda T; Ogawa K; Tsuchida K; Sugino H
Biochim Biophys Acta; 2006 Aug; 1763(8):900-6. PubMed ID: 16872693
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor beta1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation.
Fazzini M; Vallejo G; Colman-Lerner A; Trigo R; Campo S; Barañao JL; Saragüeta PE
J Cell Physiol; 2006 Apr; 207(1):40-8. PubMed ID: 16245315
[TBL] [Abstract][Full Text] [Related]
55. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta.
Vollmer G; Tan MI; Wünsche W; Frank K
Biochem Cell Biol; 1997; 75(6):759-69. PubMed ID: 9599665
[TBL] [Abstract][Full Text] [Related]
56. Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma.
Perlino E; Loverro G; Maiorano E; Giannini T; Cazzolla A; Napoli A; Fiore MG; Ricco R; Marra E; Selvaggi L
Br J Cancer; 1998 Apr; 77(8):1260-6. PubMed ID: 9579831
[TBL] [Abstract][Full Text] [Related]
57. Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma.
Suzuki Y; Shibata K; Kikkawa F; Kajiyama H; Ino K; Nomura S; Tsujimoto M; Mizutani S
Clin Cancer Res; 2003 Apr; 9(4):1528-34. PubMed ID: 12684429
[TBL] [Abstract][Full Text] [Related]
58. Activin A inhibits growth and hexamethylene bisacetamide-induced differentiation in human retinoblastoma Y-79 cells.
Zhang Z; Batres Y; Ying SY
Anticancer Res; 1996; 16(1):269-72. PubMed ID: 8615619
[TBL] [Abstract][Full Text] [Related]
59. [Activin and activin receptors in related gynecologic and obstetric diseases].
Li H; Huang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):896-902. PubMed ID: 20818087
[TBL] [Abstract][Full Text] [Related]
60. Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration.
Funaba M; Ikeda T; Ogawa K; Murakami M; Abe M
J Leukoc Biol; 2003 Jun; 73(6):793-801. PubMed ID: 12773512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
